Le Lézard
Classified in: Health
Subject: CCA

Azenta Announces Fiscal 2023 First Quarter Earnings Conference Call and Webcast


BURLINGTON, Mass., Feb. 6, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2023 earnings which ended on December 31, 2022 on Wednesday, February 8, 2023 after the market closes.

The Company will host a conference call and live webcast to discuss its financial results on the same day, Wednesday, February 8, 2023, at 4:30 p.m. Eastern Time. To participate in the conference call, please dial 800-908-8386 for domestic callers and +1-212-231-2924 for international callers.

Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on February 9, 2023.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:

Sara Silverman
Head of Investor Relations & Corporate Communications
[email protected]

Sherry Dinsmore
[email protected]

 

Azenta logo (PRNewsfoto/Azenta)

 

SOURCE Azenta


These press releases may also interest you

25 mar 2023
Recognizing China for its support during the pandemic, the Senate of the Dominican Republic recently presented China with an award. The Senate's Vice President Santiago Zorrilla said at the award ceremony that the Dominican Republic will always...

25 mar 2023
Recognizing China for its support during the pandemic, the Senate of the Dominican Republic recently presented China with an award. The Senate's Vice President Santiago Zorrilla said at the award ceremony that the Dominican Republic will always...

25 mar 2023
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced final overall survival data and an evaluation of sequence of therapy in the pivotal SORAYA trial of mirvetuximab...

25 mar 2023
COLUMVI® (glofitamab for injection) is the first fixed treatment duration CD20xCD3 T-cell engaging bispecific antibody approved in Canada, and globally, to treat diffuse large B-cell lymphoma1, 2, 3Authorization is based on results from the phase...

24 mar 2023
Speak Up Women Announces April 2023 Conference with A Spectacular Agenda & Lineup of Keynote & Featured Speakers & Panel Discussions That Will Amplify the Importance of Speaking Up At Home, In the Workplace, and For Causes She Cares About Plus...

24 mar 2023
The "Pulse Oximeters, Spirometers Global Market Report 2023" report has been added to  ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the...



News published on 6 february 2023 at 16:35 and distributed by: